Literature DB >> 23246463

Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.

Margarita K Lay1, Pablo A González, Miguel A León, Pablo F Céspedes, Susan M Bueno, Claudia A Riedel, Alexis M Kalergis.   

Abstract

This article reviews aspects of respiratory syncytial virus (RSV) infection in airway epithelial cells (AECs), including cytopathogenesis, entry, replication and the induction of immune response to the virus, including a new role for thymic stromal lymphopoietin in RSV immunopathology.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23246463     DOI： 10.1016/j.micinf.2012.11.012

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  27 in total

1.  Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Authors:  Xuancheng Guo; Taixiang Liu; Hengfei Shi; Jingjing Wang; Ping Ji; Hongwei Wang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 2.  Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Authors:  Homero San-Juan-Vergara; Mark E Peeples
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-22       Impact factor: 3.479

Review 3.  Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity.

Authors:  Paul M Brown; Dana L Schneeberger; Giovanni Piedimonte
Journal:  Paediatr Respir Rev       Date:  2015-05-23       Impact factor: 2.726

4.  Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.

Authors:  Luis Didier González-García; Macario Martínez-Castillo; Tania Allin Vargas-Pavía; José Manuel Ulloa-Aguilar; Haruki Arévalo-Romero; Guadalupe Léon-Reyes; Addy Cecilia Helguera-Repetto; Julio García-Cordero; Moisés León-Juárez
Journal:  Arch Virol       Date:  2021-02-12       Impact factor: 2.574

5.  Characterization of a respiratory syncytial virus L protein inhibitor.

Authors:  Choi-Lai Tiong-Yip; Lisa Aschenbrenner; Kenneth D Johnson; Robert E McLaughlin; Jun Fan; SreeRupa Challa; Hui Xiong; Qin Yu
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

Review 6.  Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Authors:  Janyra A Espinoza; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

7.  Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Authors:  Philippa Hillyer; Rachel Shepard; Megan Uehling; Mina Krenz; Faruk Sheikh; Kalyn R Thayer; Lei Huang; Lihan Yan; Debasis Panda; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Raymond P Donnelly; Ronald L Rabin
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

8.  The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.

Authors:  K M McCutcheon; R Jordan; M E Mawhorter; S L Noton; J G Powers; R Fearns; T Cihlar; M Perron
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

9.  Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.

Authors:  Manuel Mata; Isidoro Martinez; Jose A Melero; Herman Tenor; Julio Cortijo
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model.

Authors:  Aaron R Everitt; Simon Clare; Jacqueline U McDonald; Leanne Kane; Katherine Harcourt; Malika Ahras; Amar Lall; Christine Hale; Angela Rodgers; Douglas B Young; Ashraful Haque; Oliver Billker; John S Tregoning; Gordon Dougan; Paul Kellam
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.